GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nidan Laboratories and Healthcare Ltd (NSE:NIDAN) » Definitions » Gross-Profit-to-Asset %

Nidan Laboratories and Healthcare (NSE:NIDAN) Gross-Profit-to-Asset % : 0.00% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Nidan Laboratories and Healthcare Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Nidan Laboratories and Healthcare's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₹0.0 Mil. Nidan Laboratories and Healthcare's average Total Assets over the quarter that ended in Mar. 2024 was ₹834.8 Mil. Therefore, Nidan Laboratories and Healthcare's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 0.00%.

Nidan Laboratories and Healthcare Gross-Profit-to-Asset % Historical Data

The historical data trend for Nidan Laboratories and Healthcare's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nidan Laboratories and Healthcare Gross-Profit-to-Asset % Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 44.50 36.72 37.37 26.81 27.75

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial 54.54 26.94 30.49 22.79 -

Competitive Comparison of Nidan Laboratories and Healthcare's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Nidan Laboratories and Healthcare's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nidan Laboratories and Healthcare's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Nidan Laboratories and Healthcare's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Nidan Laboratories and Healthcare's Gross-Profit-to-Asset % falls into.


;
;

Nidan Laboratories and Healthcare Gross-Profit-to-Asset % Calculation

Nidan Laboratories and Healthcare's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=231.641/( (844.016+825.508)/ 2 )
=231.641/834.762
=27.75 %

Nidan Laboratories and Healthcare's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=0/( (844.016+825.508)/ 2 )
=0/834.762
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Nidan Laboratories and Healthcare Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Nidan Laboratories and Healthcare's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nidan Laboratories and Healthcare Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nidan Laboratories and Healthcare Ltd (NSE:NIDAN) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
BOM:539267 BOM:542918 BOM:526301 BOM:540729 BOM:544220 BOM:541299 BOM:526504 BOM:540788 BOM:526546 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX
Traded in Other Exchanges
N/A
Address
Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303
Website
https://www.nidanhealthcare.co.in
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.

Nidan Laboratories and Healthcare Headlines

No Headlines